BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 24434958)

  • 1. [Medication-based therapy of infantile hemangioma and lymphatic malformations].
    Rössler J; Braunschweiger F; Schill T
    HNO; 2014 Jan; 62(1):12-8. PubMed ID: 24434958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Propranolol-resistant infantile hemangioma successfully treated with sirolimus.
    Dávila-Osorio VL; Iznardo H; Roé E; Puig L; Baselga E
    Pediatr Dermatol; 2020 Jul; 37(4):684-686. PubMed ID: 32323340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of infantile hemangiomas with sirolimus in a patient with PHACE syndrome.
    Kaylani S; Theos AJ; Pressey JG
    Pediatr Dermatol; 2013; 30(6):e194-7. PubMed ID: 23316753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Initial experiences with propranolol treatment of infantile hemangiomas: report of three cases.
    Halilbasic A; Hotic N; Husaric E; Rahmanovic E; Halilbasic M; Husaric S
    Med Arh; 2011; 65(6):380-2. PubMed ID: 22299307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Infantile hemangioma and propranolol: a therapeutic "revolution". Literature review].
    Yilmaz L; Dangoisse C; Semaille P
    Rev Med Brux; 2013; 34(6):479-84. PubMed ID: 24505868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hemangioma. New aspects of pathogenesis, differential diagnosis and therapy].
    Höger PH
    Hautarzt; 2012 Feb; 63(2):112-20. PubMed ID: 22349036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Benign aggressive vascular anomalies in children].
    Boccara O; Maruani A; Léauté-Labrèze C
    Bull Cancer; 2018 Jun; 105(6):610-625. PubMed ID: 29571951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Head and neck vascular lesions.
    Hoff SR; Rastatter JC; Richter GT
    Otolaryngol Clin North Am; 2015 Feb; 48(1):29-45. PubMed ID: 25439548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infantile Hemangiomas in the Head and Neck Region.
    Adams DM; Ricci KW
    Otolaryngol Clin North Am; 2018 Feb; 51(1):77-87. PubMed ID: 29217069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Infantile hemangioma: a new indication for propranolol? Retrospective study: a case-series of 25 infants].
    Yilmaz L; Dangoisse C; Semaille P
    Rev Med Brux; 2015; 36(1):3-9. PubMed ID: 25856965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum concentrations of VEGF and bFGF in the course of propranolol therapy of infantile hemangioma in children: Are we closer to understand the mechanism of action of propranolol on hemangiomas?
    Babiak-Choroszczak L; Giżewska-Kacprzak K; Gawrych E; Fischer K; Walecka A; Puchalska-Niedbał L; Rajewska-Majchrzak J; Bagłaj M
    Adv Clin Exp Med; 2018 May; 27(5):703-710. PubMed ID: 29790692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Propranolol for problematic head and neck hemangiomas: an analysis of 37 consecutive patients.
    Lv MM; Fan XD; Su LX
    Int J Pediatr Otorhinolaryngol; 2012 Apr; 76(4):574-8. PubMed ID: 22326207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Propranolol vs prednisolone for symptomatic proliferating infantile hemangiomas: a randomized clinical trial.
    Bauman NM; McCarter RJ; Guzzetta PC; Shin JJ; Oh AK; Preciado DA; He J; Greene EA; Puttgen KB
    JAMA Otolaryngol Head Neck Surg; 2014 Apr; 140(4):323-30. PubMed ID: 24526257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [What's new about infantile hemangiomas?].
    Dreyfus I; Maza A; Mazereeuw-Hautier J
    Arch Pediatr; 2013 Jul; 20(7):809-16. PubMed ID: 23628116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment for Infantile Hemangiomas: Selection Criteria, Safety, and Outcomes Using Oral Propranolol During the Early Phase of Propranolol Use for Hemangiomas.
    MacIsaac ZM; Nayar HS; Gehris R; Mehta D; Geisler S; Grunwaldt LJ
    J Craniofac Surg; 2016 Jan; 27(1):159-62. PubMed ID: 26674892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Propranolol for treatment of infantile hemangiomas.
    Melo JN; Rotter A; Rivitti-Machado MC; Oliveira ZN
    An Bras Dermatol; 2013; 88(6 Suppl 1):220-3. PubMed ID: 24346925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral Propranolol for the Treatment of Infantile Hemangiomas in the Post-Proliferative Phase: A-Single Center Retrospective Study of 31 Cases.
    Tian Y; Xu DP; Tong S; Xi SL; Liu ZM; Wang XK
    J Oral Maxillofac Surg; 2016 Aug; 74(8):1623-9. PubMed ID: 27055227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Propranolol for infantile hemangiomas: early experience at a tertiary vascular anomalies center.
    Buckmiller LM; Munson PD; Dyamenahalli U; Dai Y; Richter GT
    Laryngoscope; 2010 Apr; 120(4):676-81. PubMed ID: 20112413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chinese experts consensus on the use of oral propranolol for treatment of infantile hemangiomas].
    Zheng JW; Wang XK; Qin ZP; Fan XD; Li K; Yang YW; Huo R; Liu SH; Zhao JH; Wang XY; Zhou DK
    Shanghai Kou Qiang Yi Xue; 2016 Jun; 25(3):257-60. PubMed ID: 27609372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diffuse Hepatic Hemangiomas Successfully Treated Using Sirolimus and High-Dose Propranolol.
    Warren D; Diaz L; Levy M
    Pediatr Dermatol; 2017 Sep; 34(5):e286-e287. PubMed ID: 28730754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.